You are here

Article Text

Article menu
Download PDFPDF
Short report
Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease
  1. M W Beresford1,
  2. R Primhak2,
  3. N V Subhedar1,
  4. N J Shaw1
  1. 1Royal Liverpool Children's NHS Trust, Alder Hey, UK
  2. 2Sheffield Children's Hospital NHS Trust, UK
  1. Correspondence to:
    Dr N J Shaw, Neonatal Unit, Liverpool Women's Hospital, Liverpool L8 7SS, UK;
    ben.shaw{at}lwh-tr.nwest.nhs.uk

Abstract

In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.

  • fluticasone
  • chronic lung disease
  • double blind
  • randomised

https://doi.org/10.1136/fn.87.1.F62

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    Linked Articles

    • Fantoms
      Fantoms
      Ben Stenson
      Archives of Disease in Childhood - Fetal and Neonatal Edition 2002; 87 F2-F2 Published Online First: 01 Jul 2002. doi: 10.1136/fn.87.1.F2-a